No Data
No Data
There Are Reasons To Feel Uneasy About Shandong Weigao Orthopaedic Device's (SHSE:688161) Returns On Capital
Shandong Weigao Orthopedic Materials Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Shandong Weigao Orthopedic Materials Co., Ltd.
Weigao Orthopedics (688161.SH): Has accumulated repurchased 0.679% of shares.
On August 28th, Gelonhui announced that as of August 27th, 2024, the company's share repurchase plan has been completed. The company has repurchased a total of 2,713,876 shares through centralized auction trading, accounting for 0.679% of the total share capital. The highest repurchase price was 42.40 yuan/share, the lowest price was 18.88 yuan/share, and the average repurchase price was 29.46 yuan/share. The total amount paid was 79,962,379.43 yuan (excluding stamp duty, transaction fees, and other transaction costs).
Weigao Orthopedics (688161.SH) released its performance for the first half of the year, with a net income of 93.1299 million yuan, a year-on-year decrease of 16.67%.
Orthopedics of Weigao (688161.SH) released the semi-annual report for 2024, with the company achieving revenue of 7...
Weigao Group (01066): Weigao Orthopedics (688161.SH) net income in the first half of the year was 93,129,900 yuan, a decrease of 16.67% year-on-year.
Weigao Group (01066) announced that Shandong Weigao Orthopedic Materials Co., Ltd. (Weigao Orthopedics, 688161....
No Data
No Data